Published in Women's Health Weekly, March 23rd, 2006
Investigators in Germany conducted a study "to describe the characteristics, of women seeking treatment for symptoms of urinary incontinence (UI) in European countries."
"Prospective urinary incontinence research (PURE) was a 6-month, observational, pan-European Study, primarily aimed at determining the direct costs of urinary incontinence treatment," explained D. Sykes and colleagues of Eli Lilly and Company Limited. The secondary objectives of PURE were to describe the impact of UI on health-related quality of life (HRQoL) in treatment seeking patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.